BIYKEM BOZKURT to Clinical Trials as Topic
This is a "connection" page, showing publications BIYKEM BOZKURT has written about Clinical Trials as Topic.
Connection Strength
1.348
-
Designing Next-Generation Cardiometabolic Outcome Trials for Obesity Medicines. J Am Coll Cardiol. 2026 Apr 21; 87(15):1936-1949.
Score: 0.170
-
Subgroups and Special Populations in Heart Failure Clinical Trials: Insights From the HFC-ARC Expert Consensus Panel. JACC Heart Fail. 2026 Apr; 14(4):102775.
Score: 0.168
-
Treatment of Obesity in Heart?Failure: The New Era in the Aftermath of the STEP-HFpEF and SELECT Trials. JACC Heart Fail. 2024 Jul; 12(7):1309-1313.
Score: 0.152
-
Ending Gender Inequality in Cardiovascular Clinical Trial Leadership: JACC Review Topic of the Week. J Am Coll Cardiol. 2021 06 15; 77(23):2960-2972.
Score: 0.123
-
Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J. 2020 06 07; 41(22):2109-2117.
Score: 0.114
-
Update in recent clinical trials in heart failure. Curr Opin Cardiol. 2019 07; 34(4):307-314.
Score: 0.107
-
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). J Nucl Cardiol. 2015 Oct; 22(5):1041-144.
Score: 0.083
-
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). Circulation. 2015 Jul 28; 132(4):302-61.
Score: 0.078
-
2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). J Am Coll Cardiol. 2015 Jul 28; 66(4):403-69.
Score: 0.078
-
ACC/AHA 2013 methodology for developing clinical data standards: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards. Circulation. 2014 Jun 03; 129(22):2346-57.
Score: 0.073
-
Cardiovascular toxicity with highly active antiretroviral therapy: review of clinical studies. Cardiovasc Toxicol. 2004; 4(3):243-60.
Score: 0.037
-
Use of biomarkers in the management of heart failure: are we there yet? Circulation. 2003 Mar 11; 107(9):1231-3.
Score: 0.035
-
Design of the remede System Therapy (reST) study: A prospective non-randomized post-market study collecting clinical data on safety and effectiveness of the remede system for the treatment of central sleep apnea. Sleep Med. 2022 12; 100:238-243.
Score: 0.033
-
Heart Failure Site-Based Research in?the United States: Results of the Heart Failure Society of America Research?Network Survey. JACC Heart Fail. 2019 05; 7(5):431-438.
Score: 0.026
-
Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2017 May 30; 135(22):e1054-e1091.
Score: 0.023
-
Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012 Oct 16; 60(16):1581-98.
Score: 0.017
-
2012 ACCF/AHA/ACR/SCAI/SIR/STS/SVM/SVN/SVS key data elements and definitions for peripheral atherosclerotic vascular disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Peripheral Atherosclerotic Vascular Disease). Circulation. 2012 Jan 17; 125(2):395-467.
Score: 0.016
-
Trials on the effect of cardiac resynchronization on arterial blood pressure in patients with heart failure. Am J Cardiol. 2011 Feb 15; 107(4):561-8.
Score: 0.015